Discovery and validation of a prognostic proteomic signature for tuberculosis 
progression: A prospective cohort study

Penn-Nicholson, Adam; Hraha, Thomas; Thompson, Ethan G.; Sterling, David; Mbandi, Stanley Kimbung; Wall, Kirsten M.; Fisher, Michelle; Suliman, Sara; Shankar, Smitha; Hanekom, Willem A.; Janjic, Nebojsa; Hatherill, Mark; Kaufmann, Stefan H. E.; Sutherland, Jayne; Walzl, Gerhard; Groote, Mary Ann De; Ochsner, Urs; Zak, Daniel E.; Scriba, Thomas J.

doi:10.1371/journal.pmed.1002781

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study

MPS-Authors

/persons/resource/persons81969

Kaufmann, Stefan H. E.
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource

https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002880
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

PLoS_Med_2019_16_1002781.pdf
(Publisher version), 3MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Penn-Nicholson, A., Hraha, T., Thompson, E. G., Sterling, D., Mbandi, S. K., Wall, K. M., et al. (2019). Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study. PLoS Medicine, 16(4): e1002781. doi:10.1371/journal.pmed.1002781.

Cite as: https://hdl.handle.net/21.11116/0000-0003-8A4F-A

Abstract

There is no abstract available